A study for a 24 year old woman who takes Gravol, Wellbutrin Xl (an AI-powered real world drug study)

Summary:

22 females aged 24 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 24 year old female patient who has Nausea, Depression. The study is created by eHealthMe based on reports from sources including the FDA.

On Aug, 02, 2026

22 females aged 24 (±5) who take Gravol, Wellbutrin Xl and have adverse effects are studied.

Number of reports submitted per year:

Gravol, Wellbutrin Xl for a 24-year old woman.

Information of the patient in this study:

Age: 24
Gender: female

What are the drugs?

Gravol has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 7,192 Gravol users. Check the latest studies of Gravol.
Wellbutrin xl has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 22,999 Wellbutrin xl users. Check the latest studies of Wellbutrin xl.

What are the conditions?

Nausea (feeling of having an urge to vomit) is found to be associated with 3,891 drugs and 5,634 conditions by eHealthMe. Check the latest studies of Nausea.
Depression is found to be associated with 3,168 drugs and 4,126 conditions by eHealthMe. Check the latest studies of Depression.

Common drug interactions *:

Headache (pain in head): 11 people, 50.00%
Cough : 9 people, 40.91%
White Blood Cell Count Decreased : 8 people, 36.36%
Blood Creatinine Increased : 8 people, 36.36%
Lymphocyte Count Decreased : 8 people, 36.36%
Memory Loss : 8 people, 36.36%
Blood Thyroid Stimulating Hormone Increased : 7 people, 31.82%
Urine Abnormality : 7 people, 31.82%
Dyspnea (difficult or laboured breathing): 7 people, 31.82%
Weight Increased : 6 people, 27.27%
Blood Thyroid Stimulating Hormone Decreased : 6 people, 27.27%
Urinary Tract Infection : 6 people, 27.27%
Pain : 5 people, 22.73%
Abdominal Pain : 5 people, 22.73%
Speech Impairment (Adult) (inability to speak (adult)): 4 people, 18.18%
Monocyte Count Decreased : 4 people, 18.18%
Thrombocytopenia (decrease of platelets in blood): 4 people, 18.18%
Limb Discomfort (discomfort in leg): 4 people, 18.18%
Leukopenia (less number of white blood cells in blood): 4 people, 18.18%
Irritability : 4 people, 18.18%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 11 people, 50.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 27.27%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 5 people, 22.73%
Sleep Disorder : 4 people, 18.18%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 18.18%
Feeling Abnormal : 3 people, 13.64%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 9.09%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.09%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 9.09%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

Drug effectiveness *:

Gravol:

n/a

Wellbutrin Xl:

n/a

* Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Gravol: 7,192 reports
Wellbutrin xl: 22,999 reports

Treatments, associated medications and conditions:

Depression: 652,152 reports
Nausea: 962,089 reports

Drug interactions:

Gravol and Wellbutrin xl drug interaction (15 reports)

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.